Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Policy / Pricing

Kennedy changes vaccine panel charter after legal setback

 April 7, 2026

Pharmaphorum

A change to the ACIP charter has raised concerns of even greater political influence over the vaccine panel by HHS Secretary Kennedy.

Policy / PricingRead full story

Post navigation

Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease →
← AbbVie Puts Humira on TrumpRx at Steep Discount as Tariff Threat Solidifies

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com